Neuroprotection in hypoxic-ischemic brain injury targeting glial cells
Autor
Mucci S.
Herrera M.I.
Barreto G.E.
Kolliker-Frers R.
Capani F.
Resumen
Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action. © 2017 Bentham Science Publishers.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Review
Neuroprotective role of hypothermia in hypoxic-ischemic brain injury: Combined therapies using estrogen (2020)
Toro-Urrego N.; Vesga-Jiménez D.J.; Herrera M.I.; Luaces J.P.; Capani F. (Bentham Science Publishers, 2019) -
Review
Pathophysiology of blood-brain barrier in brain injury in cold and hot environments: Novel drug targets for neuroprotection (2020)
Sharma H.S.; Muresanu D.F.; Lafuente J.V.; Nozari A.; Patnaik R.; Skaper S.D.; Sharma A. (Bentham Science Publishers B.V., 2016) -
Review
Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system (2020)
González-Giraldo Y.; Forero D.A.; Echeverria V.; Gonzalez J.; Ávila-Rodriguez M.; Garcia-Segura L.M.; Barreto G.E. (Elsevier Ireland Ltd, 2016)